Birmingham Centre for Energy Storage

Chromatwist develops innovative fluorescent dyes that become visible under UV light. Their patented technology platform enables the creation of fluorophores used in bio-sensing (like flow cytometry) and bio-imaging (such as multiphoton microscopy) within the healthcare sector.

Chromatwist develops innovative fluorescent dyes that become visible under UV light. Their patented technology platform enables the creation of fluorophores used in bio-sensing (like flow cytometry) and bio-imaging (such as multiphoton microscopy) within the healthcare sector.

Linear Diagnostics develops a proprietary diagnostic platform technology that enables rapid, simultaneous detection of multiple targets using a single reagent. Its core innovation, linear dichroism, facilitates molecular diagnostics tests across various sectors, including infectious diseases and food safety.

Tyseley Energy Park develops an Energy Innovation Zone (EIZ) to help Tyseley and Birmingham overcome the severe energy business and social challenges it currently faces. The TEP EIZ reduces emissions and stimulates growth and will integrate low carbon technologies and infrastructure needed to support new approaches to clean energy.

Smart Antenna Technologies Ltd specializes in the design and development of innovative smart antenna systems targeted at the mobile device and infrastructure market. Founded in 2013 as a spinout from the University of Birmingham, the company has developed patented technology that offers compact, multi-band, multi-functional, and multi-port antenna solutions. These solutions are applicable across various devices, including smartphones, laptops, tablets, small cells, Internet of Things devices, and automotive applications. By replacing multiple existing antennas with a single device, Smart Antenna Technologies significantly reduces the size, cost, and complexity of antenna systems while enhancing performance and battery life. The company caters to handset manufacturers and industry partners across the United States, Europe, South Korea, Japan, and China, fulfilling the growing demand for advanced antenna solutions compliant with next-generation cellular technologies.

Cytox Limited is a company focused on developing innovative products and services for the diagnosis and treatment of neurodegenerative disorders, particularly Alzheimer's disease. Established in 2004 and headquartered in Birmingham, UK, with additional offices in Manchester and Oxford, Cytox has created a genetic-based blood test that assesses the risk and early diagnosis of Alzheimer's disease, which currently affects millions worldwide. The company employs cellular and genetic assays to identify early cell cycle deficits in patients, aiding pharmaceutical and biotechnology companies in clinical trials and drug development for Alzheimer's and mild cognitive impairment. Cytox's strategic partnership with Affymetrix, part of Thermo Fisher Scientific, enhances its capabilities in delivering these assessments and supporting the development of novel therapeutics.